Four consecutive weeks of decline have left India's benchmark Nifty 50 index at a crossroads familiar to markets throughout history — the moment when momentum shifts from hope to caution, and technical signals begin to speak louder than sentiment. Analysts at SBI Securities now read the chart as one tilted toward further weakness, with the index having broken below its rising channel and key moving averages turning downward across multiple timeframes. External forces — geopolitical friction, rising US bond yields, and elevated crude prices — have joined the internal deterioration, leaving the
Nifty 50 poised to test 23,600-23,500 support as bearish technicals dominate
Everything is pointing the same direction—that's what makes the bearish case credible.
Mark
So the Nifty has fallen four weeks in a row. Is that unusual enough to matter, or is this just normal market chop?
Mimi
Four consecutive weeks of losses is significant because it shows persistent selling pressure at higher levels. Combined with the break below the rising channel and the moving averages all sloping downward, it's not just noise—it's a shift in the underlying trend.
Luke
But how much of that selling is driven by the external factors Shah mentions—geopolitical tensions, bond yields, oil prices—versus something structural in the Indian market itself? Those are global headwinds, not India-specific.
Mimi
That's a fair point. The external factors are real, but they're also somewhat beyond the control of Indian policymakers. What matters for traders is that they're weighing on sentiment right now, and the technicals are reflecting that.
Mark
The RSI is at 40 and below its 9-day average. Does that mean the market is oversold and due for a bounce?
Luke
Not necessarily. Oversold doesn't mean it has to bounce immediately. The ADX is rising and pointing downward, which means the downtrend is actually strengthening. You can have a market that stays weak for a while.
Mimi
Exactly. The technical setup is internally consistent—everything is pointing the same direction. That's what makes Shah's call for a test of 23,500 credible. It's not one indicator; it's the whole picture.
Mark
What about the Smallcap 100 outperforming? Does that suggest money is rotating to safety, or is it something else?
Mimi
It could be rotation, or it could be that smaller-cap stocks have their own momentum independent of the Nifty. The Smallcap 100 hit fresh all-time highs and is holding above its trendline, so there's genuine strength there.
Luke
But we should note that the Midcap 100 is underperforming and below its 20-day moving average. So it's not a broad-based rally in mid and small caps—it's specifically the small caps that are holding up. That's a narrower story.
Mark
And Nifty Pharma—Shah says it's likely to consolidate rather than break down. How confident is he in that call?
Mimi
He's saying the primary uptrend is still intact because the index maintains higher highs and higher lows. But he's also acknowledging that momentum has moderated and the index is below its 20-day moving average. So it's consolidation within an uptrend, not a resumption of the rally.
Luke
The key phrase there is "as long as key swing support levels remain intact." That's a conditional statement. If those support levels break, the whole thesis changes. We don't know yet where those exact levels are.
Der Puls
- The Nifty 50 has fallen for four straight weeks, breaking below its rising channel and slipping beneath its 20, 50, and 100-day moving averages — all of which are now pointing lower.
- Momentum indicators tell a bearish story: the daily RSI is hovering near 40 and below its own signal line, while a rising ADX confirms the downtrend is gaining rather than losing conviction.
- Global headwinds — geopolitical tensions, climbing US 10-year yields, and elevated Brent crude — have amplified domestic selling pressure, turning a technical retreat into a broader risk-off mood.
- A modest bounce from 23,786 offered brief relief, but analysts characterize it as a technical rebound rather than a genuine reversal, with resistance firmly capping upside at 24,150-24,200.
- Critical support at 23,750-23,700 — coinciding with the 61.8% Fibonacci retracement — must hold or the index risks extending losses toward 23,500 and then 23,300.
- Amid the large-cap gloom, Nifty Smallcap 100 has bucked the trend with fresh all-time highs, while select stocks like Yatharth Hospital and KPR Mill offer traders defined-risk bullish setups.
Four consecutive weeks of decline have left India's benchmark Nifty 50 index at a crossroads familiar to markets throughout history — the moment when momentum shifts from hope to caution, and technical signals begin to speak louder than sentiment. Analysts at SBI Securities now read the chart as one tilted toward further weakness, with the index having broken below its rising channel and key moving averages turning downward across multiple timeframes. External forces — geopolitical friction, rising US bond yields, and elevated crude prices — have joined the internal deterioration, leaving the market to reckon with support levels around 23,600-23,500 as the more probable near-term destination than any sustained recovery above 24,000.
India's Nifty 50 is sending distress signals that technical analysts find difficult to dismiss. After four consecutive weeks of losses, the index has broken below the rising channel that had defined its short-term trajectory, and its key moving averages — the 20, 50, and 100-day exponential averages — have all begun to slope downward. Sudeep Shah of SBI Securities puts the odds plainly: a break below 23,600-23,500 is more likely in the coming week than any meaningful rally above 24,000-24,200.
The momentum picture reinforces that view. The daily RSI sits near 40 and below its own 9-day average, a sign that buying conviction has faded. The ADX, which measures trend strength, has climbed above 20 and continues to rise — but here it is amplifying the downtrend rather than hinting at a turn. External pressures have added to the weight: geopolitical tensions, rising US bond yields, and elevated crude oil prices have all dampened investor appetite. A brief bounce from 23,786 offered some relief, but Shah described it as technical in nature — a pause, not a pivot.
The key levels to watch are well-defined. Immediate support sits at 23,750-23,700, which aligns with the 61.8% Fibonacci retracement of the prior rally. A decisive break there opens the door to 23,500 and then 23,300. On the upside, the 50-day and 100-day moving averages converge near 24,150-24,200, forming a resistance ceiling that must be cleared before any bullish case can be made.
The broader market tells a more nuanced story. The Nifty Smallcap 100 has outperformed sharply, reaching fresh all-time highs and holding its upward trendline — a pocket of genuine strength. The Midcap 100, however, has slipped below its 20-day average and lacks directional clarity. Nifty Pharma, despite recent softness, retains its structure of higher highs and higher lows, suggesting consolidation rather than collapse as the more likely outcome.
For active traders, Shah identified two stocks with constructive setups. Yatharth Hospital broke out of a multi-month consolidation range on strong volume and continues to trade above its moving averages, with the RSI above 60 and ADX rising — accumulation is suggested between Rs 985-995, targeting Rs 1,065. KPR Mill has pulled back to its 34-day moving average in an orderly fashion, with momentum indicators strengthening; the suggested entry zone is Rs 1,175-1,190, with a target of Rs 1,270.
The Indian stock market's benchmark index is flashing red lights. The Nifty 50 has closed lower for four straight weeks, and the technical picture has deteriorated sharply enough that analysts are now betting on a test of support levels well below where the index currently trades. Sudeep Shah, head of technical and derivatives research at SBI Securities, laid out the case in plain terms: the odds favor a break below 23,600-23,500 over the coming week rather than any sustained rally above 24,000-24,200.
The weakness runs deeper than a single bad week. The index has broken below its rising channel on the daily chart—a shift that signals the short-term trend has turned. More telling still, the Nifty is now trading beneath its key moving averages across multiple timeframes. The 20, 50, and 100-day exponential moving averages have all begun to slope downward, a visual confirmation that price momentum is fading. The daily RSI, a measure of buying and selling pressure, is hovering near 40 and sitting below its own 9-day average, suggesting that bullish conviction has largely evaporated. The ADX, which measures trend strength, has climbed above 20 and continues rising—but in this case, it is reinforcing the downward bias rather than signaling a reversal.
External headwinds have compounded the technical deterioration. Geopolitical tensions, climbing US 10-year bond yields, and elevated Brent crude oil prices have all weighed on investor appetite. The index did bounce modestly after testing 23,786, but Shah characterized that rebound as technical in nature—a relief rally rather than the start of something more durable. The broader setup, he said, continues to favor the bears.
From a technical standpoint, the immediate support zone sits at 23,750-23,700, a level that coincides with the 61.8 percent Fibonacci retracement of the prior move from 23,070 to 24,774. If the index breaks decisively below that zone, weakness could extend toward 23,500, then 23,300. On the upside, strong resistance is clustered around 24,150-24,200, where the 50-day and 100-day moving averages converge. Unless the Nifty manages to hold above that hurdle, the bearish bias is likely to persist.
Within the broader market, the picture is mixed. The Nifty Smallcap 100 has outperformed, hitting fresh all-time highs and holding above its upward-sloping trendline, suggesting strength in the smaller-cap space. The Nifty Midcap 100, by contrast, has slipped below its 20-day moving average and shows little directional conviction. For the Midcap index, support is expected around 62,400-62,600, with resistance at 63,800-64,000. The Smallcap index, meanwhile, should find support near its 20-day EMA zone of 19,850-19,900; as long as it holds there, the uptrend remains intact and could push toward 20,300 and 20,500.
Nifty Pharma presents a different narrative. Despite recent weakness—the index has slipped below its 20-day moving average and the daily RSI has fallen below its previous swing low—the broader uptrend remains structurally sound. The index continues to mark higher highs and higher lows, the hallmark of a primary uptrend. Shah sees consolidation or range-bound trading as more likely than a breakdown, provided key swing support levels hold.
For traders looking for opportunities, Shah identified two stocks with bullish setups. Yatharth Hospital and Trauma Care Services broke out of a Rs 920-776 consolidation range last week on healthy volume and has continued to climb this week, trading above its key moving averages. The ADX is rising on both weekly and daily charts, and the RSI has turned higher and settled above 60, signaling renewed momentum. Accumulation is recommended in the Rs 985-995 zone with a stop-loss at Rs 955, with a near-term target of Rs 1,065. KPR Mill has also pulled back to its 34-day moving average and is trading above key averages with rising RSI and strengthening ADX on both timeframes. Accumulation is suggested in the Rs 1,175-1,190 zone with a stop-loss at Rs 1,140, targeting Rs 1,270 in the near term.
Bemerkenswerte Zitate
The probability of Nifty 50 breaking below the 23,600-23,500 zone appears higher than a sustained move above the 24,000-24,200 zone in the coming week.— Sudeep Shah, Head of Technical and Derivatives Research, SBI Securities
The broader technical setup continues to favour the bears. Nifty is trading below its key short and medium-term moving averages, while momentum indicators remain subdued.— Sudeep Shah, SBI Securities
Möchten Sie die ganze Geschichte?
Das Original lesen bei Moneycontrol.com ↗
Economy & Finance